100 results
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
and Healthcare products Regulatory Agency, Health Canada, or any other health authority and no conclusion can or should be drawn regarding the safety or efficacy
8-K
EX-99.1
w4mq06
16 Apr 24
VBI Vaccines Reports Full Year 2023 Financial Results
8:00am
424B5
lqtdb02jp9ka7skm0v
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
EX-99.1
5rzh3ojdxysbhcv8o
27 Sep 23
Regulation FD Disclosure
7:30am
8-K
EX-99.1
q9hw w4jwe0
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
424B5
iu1j419e8xqhjzkke
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
3jts grs02yf
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-1.1
38s7rtagdh1tf9i
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
ekzh3cp un7gg6d
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
do7654orimcbms5 k7
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
8-K
a05729mc64fmzb5adpg
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-99.1
p8ak4o gityf
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am